Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | TACR1 | P25103 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16933753 | 0.83 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL331127 | 0.83 | GABRA1 (0.54) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL7528890 | 0.83 | CYP1A2 (0.53) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL10456006 | 0.82 | GABRA1 (0.52) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL10456008 | 0.82 | GABRA1 (0.52) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL14667818 | 0.80 | SIGMAR1 (0.43) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL673323 | 0.80 | GABRA1 (0.41) | CYP2D6SIGMAR1SLC6A4 | |
| SCHEMBL6307855 | 0.80 | CTNNB1 (0.53) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL8377380 | 0.80 | TDP1 (0.53) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 | |
| SCHEMBL11674881 | 0.80 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2D6SIGMAR1CTNNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1829883-B1 | ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER | OTSUKA CHEMICAL CO LTD (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-7847043-B2 | Organic bismuth compound, method for producing same, living radical polymerization initiator, method for producing polymer using same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20070265404-A1 | Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1829883-A1 | ORGANIC BISMUTH COMPOUND, METHOD FOR PRODUCING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER USING SAME, AND POLYMER | Otsuka Chemical Co., Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-4046819-A | Alkylation of alkyl, cycloalkyl and aralkyl halides | UOP INC. (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265404-A1 | Organic Bismuth Compound, Method for Producing Same, Living Radical Polymerization Initiator, Method for Producing Polymer Using Same, and Polymer | DOHH, COASY, ODC1 | CYP1A2 165/4885CYP2C19 316/4885CYP2D6 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.